Science & Nature
ANVISA Approves Polylaminin: Brazil's Breakthrough Treatment for Spinal Cord Injury
ANVISA granted landmark approval for polylaminin-based therapy for spinal cord injury in April 2026, offering the first disease-modifying treatment for paralysis patients in Brazil and a potential glo
⏱️ 7 min📅 2026-04-21